Seifert et al. analyzed 85 patients with GIST to determine expression of immune checkpoint molecules and the effects of combination imatinib and PD-1/PD-L1 blockade in KitV558Δ/+ mice that develop GIST. This evidence concerns the gene CD274 and gastrointestinal stromal tumor.